Triumph Capital Management increased its position in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 41.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 40,420 shares of the company's stock after buying an additional 11,863 shares during the period. Triumph Capital Management's holdings in Celsius were worth $1,065,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also made changes to their positions in CELH. Northern Trust Corp boosted its position in shares of Celsius by 15.7% in the fourth quarter. Northern Trust Corp now owns 1,347,662 shares of the company's stock valued at $35,497,000 after acquiring an additional 183,163 shares during the period. The Manufacturers Life Insurance Company boosted its position in shares of Celsius by 1.1% in the fourth quarter. The Manufacturers Life Insurance Company now owns 130,894 shares of the company's stock valued at $3,448,000 after acquiring an additional 1,467 shares during the period. Nebula Research & Development LLC bought a new stake in shares of Celsius in the fourth quarter valued at about $613,000. T. Rowe Price Investment Management Inc. bought a new stake in shares of Celsius in the fourth quarter valued at about $8,702,000. Finally, IHT Wealth Management LLC boosted its position in shares of Celsius by 139.8% in the fourth quarter. IHT Wealth Management LLC now owns 26,864 shares of the company's stock valued at $708,000 after acquiring an additional 15,661 shares during the period. 60.95% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In related news, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the sale, the insider now directly owns 45,297 shares in the company, valued at $1,167,303.69. This represents a 18.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Joyce Russell sold 4,000 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the completion of the sale, the director now owns 19,106 shares in the company, valued at $543,947.82. The trade was a 17.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.55% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on CELH shares. Piper Sandler increased their target price on Celsius from $43.00 to $44.00 and gave the stock an "overweight" rating in a report on Thursday, April 17th. UBS Group increased their target price on Celsius from $43.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. B. Riley reissued a "buy" rating and set a $49.00 target price (up from $44.00) on shares of Celsius in a report on Friday, February 21st. Roth Mkm reissued a "buy" rating and set a $38.00 target price on shares of Celsius in a report on Friday, February 21st. Finally, Needham & Company LLC increased their target price on Celsius from $45.00 to $47.00 and gave the stock a "buy" rating in a report on Thursday, May 15th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $47.00.
Read Our Latest Stock Analysis on CELH
Celsius Stock Up 1.5%
Shares of CELH stock traded up $0.58 during mid-day trading on Tuesday, reaching $38.08. 6,151,280 shares of the stock traded hands, compared to its average volume of 7,950,549. The stock's fifty day simple moving average is $35.38 and its two-hundred day simple moving average is $29.96. Celsius Holdings, Inc. has a 1-year low of $21.10 and a 1-year high of $98.85. The company has a market cap of $9.81 billion, a price-to-earnings ratio of 86.55, a price-to-earnings-growth ratio of 2.90 and a beta of 1.65.
Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). Celsius had a net margin of 10.70% and a return on equity of 51.89%. The firm had revenue of $329.28 million for the quarter, compared to analyst estimates of $349.09 million. During the same period in the previous year, the business posted $0.27 earnings per share. The business's revenue for the quarter was down 7.4% compared to the same quarter last year. On average, equities research analysts anticipate that Celsius Holdings, Inc. will post 0.89 EPS for the current fiscal year.
About Celsius
(
Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Articles

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.